Circulating follicular helper T cells (CD4+CXCR5+ICOS+) decrease in patients with rheumatoid arthritis treated with abatacept

Clin Exp Rheumatol. 2018 Jul-Aug;36(4):685. Epub 2018 Apr 13.

Authors

Silvia Piantoni¹, Francesca Regola², Mirko Scarsi³, Angela Tincani², Paolo Airò²

Affiliations

¹ Rheumatology and Clinical Immunology Unit, Spedali Civili and University of Brescia, Italy. slv.piantoni@gmail.com.
² Rheumatology and Clinical Immunology Unit, Spedali Civili and University of Brescia, Italy.
³ Internal Medicine Unit, Esine-Vallecamonica Hospital, ASL Vallecamonica-Sebino, Esine, Italy.

PMID: 29652652

No abstract available

MeSH terms

Abatacept / therapeutic use*
Aged
Antirheumatic Agents / therapeutic use*
Arthritis, Rheumatoid / drug therapy*
Arthritis, Rheumatoid / immunology
CD4-Positive T-Lymphocytes / immunology*
Female
Humans
Inducible T-Cell Co-Stimulator Protein / analysis*
Male
Middle Aged
Receptors, CXCR5 / analysis*

Substances

Antirheumatic Agents
CXCR5 protein, human
ICOS protein, human
Inducible T-Cell Co-Stimulator Protein
Receptors, CXCR5
Abatacept